1 Genmab A Receivables Turnover Ratio (GMAB), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genmab A  (NASDAQ: GMAB)
 

Genmab A Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Genmab A's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 1231.7, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average collection period, for Genmab A's accounts receivable remained unchanged at 0 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector Genmab A achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Genmab A Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GMAB Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 377.54 % - - - -
Receivable Turnover Ratio (TTM) 1231.7 - - - -
GMAB's Total Ranking # # # # #
Accounts Receivable average collection period days 0 - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





GMAB Company Profile • Back to GMAB Efficiency Comparisons • Compare GMAB Receivables Turnover Ratio to its Competitors

Financial Statements
Genmab A's Accounts Receivable $ 15 Millions Visit GMAB's Balance sheet
Genmab A's Sales TTM $ 4,645 Millions Visit GMAB's Income Statement
Sources of GMAB's Revenues Visit GMAB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GMAB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GMAB's Growth Rates GMAB's Roa GMAB's Inventory Turnover Ratio GMAB's Dividend Comparisons
GMAB's Profitability Ratios GMAB's Roi GMAB's Asset Turnover Ratio GMAB's Dividend Growth
GMAB's Valuation Ratios GMAB's Roe GMAB's Financial Strength Ratios GMAB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Adagene Inc   563.04 $ 7.671  Millions$ 0.014  Millions
Warby Parker Inc   495.22 $ 871.579  Millions$ 1.760  Millions
Orchestra Biomed Holdings Inc   419.84 $ 33.482  Millions$ 0.080  Millions
Galapagos Nv  375.89 $ 1,245.718  Millions$ 3.314  Millions
Iqvia Holdings Inc   368.59 $ 16,310.000  Millions$ 44.250  Millions
Bausch Health Companies Inc   348.00 $ 10,266.000  Millions$ 29.500  Millions
Nakamoto Inc   345.50 $ 1.821  Millions$ 0.005  Millions
Medicure Inc   264.72 $ 22.103  Millions$ 0.083  Millions
Ginkgo Bioworks Holdings Inc   226.19 $ 170.155  Millions$ 0.752  Millions
Fortress Biotech Inc   216.84 $ 63.262  Millions$ 0.292  Millions
Zeo Scientifix Inc   200.18 $ 5.555  Millions$ 0.028  Millions
Arcus Biosciences Inc   197.60 $ 247.000  Millions$ 1.250  Millions
Immunocore Holdings Plc  181.15 $ 400.016  Millions$ 2.208  Millions
Arrowhead Pharmaceuticals Inc   169.72 $ 1,090.981  Millions$ 6.428  Millions
Earth Science Tech Inc   159.09 $ 32.891  Millions$ 0.207  Millions
Assembly Biosciences Inc   153.35 $ 72.303  Millions$ 0.472  Millions
Koninklijke Philips Nv  149.87 $ 19,974.080  Millions$ 133.280  Millions
Prime Medicine Inc   135.24 $ 4.632  Millions$ 0.034  Millions
Logicmark Inc  114.88 $ 11.426  Millions$ 0.099  Millions
Harvard Apparatus Regenerative Technology Inc   100.57 $ 0.704  Millions$ 0.007  Millions
Mangoceuticals Inc   90.95 $ 0.456  Millions$ 0.005  Millions
Sbc Medical Group Holdings Incorporated  76.66 $ 171.922  Millions$ 2.243  Millions
Aclaris Therapeutics Inc   70.50 $ 7.826  Millions$ 0.111  Millions
Agape Atp Corporation  70.27 $ 1.524  Millions$ 0.022  Millions
Humacyte Inc   67.98 $ 40.803  Millions$ 0.600  Millions

Date modified: 2026-07-07T11:25:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.